Quinine

CAS# 130-95-0

Quinine

Catalog No. BCN2341----Order now to get a substantial discount!

Product Name & Size Price Stock
Quinine: 5mg $23 In Stock
Quinine: 10mg Please Inquire In Stock
Quinine: 20mg Please Inquire Please Inquire
Quinine: 50mg Please Inquire Please Inquire
Quinine: 100mg Please Inquire Please Inquire
Quinine: 200mg Please Inquire Please Inquire
Quinine: 500mg Please Inquire Please Inquire
Quinine: 1000mg Please Inquire Please Inquire
Related Products
  • Quinidine

    Catalog No.:BCC7863
    CAS No.:56-54-2

Quality Control of Quinine

Number of papers citing our products

Chemical structure

Quinine

3D structure

Chemical Properties of Quinine

Cas No. 130-95-0 SDF Download SDF
PubChem ID 3034034 Appearance White powder
Formula C20H24N2O2 M.Wt 324.42
Type of Compound Alkaloids Storage Desiccate at -20°C
Synonyms Chinine; 6'-Methoxycinchonidine
Solubility DMSO : ≥ 100 mg/mL (308.24 mM)
H2O : < 0.1 mg/mL (insoluble)
*"≥" means soluble, but saturation unknown.
Chemical Name (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
SMILES COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
Standard InChIKey LOUPRKONTZGTKE-WZBLMQSHSA-N
Standard InChI InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Quinine

The barks of Cinchona ledgeriana (Howard) Moens ex Trim.

Biological Activity of Quinine

DescriptionQuinine is an anti-malaria agent and also a potassium channel inhibitor with an IC50 of 169 μM.Quinine is used for the treatment of acute malaria in pregnant women.
TargetsAntifection | Potassium channel
In vivo

China rubra for side-effects of quinine: a prospective, randomised study in pregnant women with malaria in Cotonou, Benin.[Pubmed: 24931747]

Homeopathy. 2014 Jul;103(3):165-71.

In endemic areas, gestational malaria is responsible for low birth weight and maternal anaemia. Quinine is the reference treatment for acute malaria in pregnant women, irrespective of term. However, Quinine administration is associated with various side-effects. We evaluated the impact of the homeopathic medicine China rubra 7CH on the side-effects of Quinine used as treatment for acute malaria in pregnant women in Cotonou, Benin.
METHODS AND RESULTS:
This prospective, comparative, randomised study was carried out between June and December 2007 in the Saint Jean-Baptiste Medical Centre, Cotonou. Women were included if they were >3 months pregnant and had a clinical diagnosis of malaria confirmed by a positive thick blood smear. The study population was divided into two groups: (i) patients who presented between the 1st and 15th of each month and who received China rubra 7CH plus Quinine (China group); and (ii) patients who presented from the 16th to the end of each month and who received treatment with Quinine only (Standard group). The aim was to compare the frequency of side-effects of Quinine in the two groups until day 6 after the start of treatment. Neither the patients nor the care givers were blinded to study treatment. Statistical comparison of the two groups was carried out with an alpha risk fixed at 5%. 211 women were recruited: 105 received Quinine plus China rubra 7CH (China group) and 106 received Quinine only (Standard group). A decrease in proportion of patients presenting with side-effects was observed in the China group from day 0 to day 6 of follow-up (53.9%-23.3%) whereas the proportion of patients with side-effects in the Standard group did not change significantly (85.9% on day 0 vs. 82.5% on day 6). Ninety-six (72.4%) patients in the China group and 103 (97.2%) in the Standard group reported at least one side-effect during follow-up (p < 0.0001). The most frequently reported side-effects were tinnitus, dizziness and asthenia.
CONCLUSIONS:
This preliminary study shows the interest of China rubra 7CH in limiting the side-effects of Quinine used for the treatment of acute malaria in pregnant women.

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.[Pubmed: 21609473 ]

Malar J. 2011 May 24;10:144.

Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented. However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs. This article reviews the historical role of Quinine, considers its current usage and provides insight into its appropriate future use in the treatment of malaria.
METHODS AND RESULTS:
In light of recent research findings intravenous artesunate should be the first-line drug for severe malaria, with Quinine as an alternative. The role of rectal Quinine as pre-referral treatment for severe malaria has not been fully explored, but it remains a promising intervention. In pregnancy, Quinine continues to play a critical role in the management of malaria, especially in the first trimester, and it will remain a mainstay of treatment until safer alternatives become available. For uncomplicated malaria, artemisinin-based combination therapy (ACT) offers a better option than Quinine though the difficulty of maintaining a steady supply of ACT in resource-limited settings renders the rapid withdrawal of Quinine for uncomplicated malaria cases risky.
CONCLUSIONS:
The best approach would be to identify solutions to ACT stock-outs, maintain Quinine in case of ACT stock-outs, and evaluate strategies for improving Quinine treatment outcomes by combining it with antibiotics. In HIV and TB infected populations, concerns about potential interactions between Quinine and antiretroviral and anti-tuberculosis drugs exist, and these will need further research and pharmacovigilance.

Protocol of Quinine

Kinase Assay

Mechanism of inhibition of mouse Slo3 (KCa 5.1) potassium channels by quinine, quinidine and barium.[Pubmed: 26045093 ]

Br J Pharmacol. 2015 Sep;172(17):4355-63.

The Slo3 (KCa 5.1) channel is a major component of mammalian KSper (sperm potassium conductance) channels and inhibition of these channels by Quinine and barium alters sperm motility. The aim of this investigation was to determine the mechanism by which these drugs inhibit Slo3 channels.
METHODS AND RESULTS:
Mouse (m) Slo3 (KCa 5.1) channels or mutant forms were expressed in Xenopus oocytes and currents recorded with 2-electrode voltage-clamp. Gain-of-function mSlo3 mutations were used to explore the state-dependence of the inhibition. The interaction between quinidine and mSlo3 channels was modelled by in silico docking. Several drugs known to block KSper also affected mSlo3 channels with similar levels of inhibition. The inhibition induced by extracellular barium was prevented by increasing the extracellular potassium concentration. R196Q and F304Y mutations in the mSlo3 voltage sensor and pore, respectively, both increased channel activity. The F304Y mutation did not alter the effects of barium, but increased the potency of inhibition by both Quinine and quinidine approximately 10-fold; this effect was not observed with the R196Q mutation.
CONCLUSIONS:
Block of mSlo3 channels by Quinine, quinidine and barium is not state-dependent. Barium inhibits mSlo3 outside the cell by interacting with the selectivity filter, whereas Quinine and quinidine act from the inside, by binding in a hydrophobic pocket formed by the S6 segment of each subunit. Furthermore, we propose that the Slo3 channel activation gate lies deep within the pore between F304 in the S6 segment and the selectivity filter.

Quinine Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Quinine Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Quinine

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.0824 mL 15.4121 mL 30.8242 mL 61.6485 mL 77.0606 mL
5 mM 0.6165 mL 3.0824 mL 6.1648 mL 12.3297 mL 15.4121 mL
10 mM 0.3082 mL 1.5412 mL 3.0824 mL 6.1648 mL 7.7061 mL
50 mM 0.0616 mL 0.3082 mL 0.6165 mL 1.233 mL 1.5412 mL
100 mM 0.0308 mL 0.1541 mL 0.3082 mL 0.6165 mL 0.7706 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Quinine

China rubra for side-effects of quinine: a prospective, randomised study in pregnant women with malaria in Cotonou, Benin.[Pubmed:24931747]

Homeopathy. 2014 Jul;103(3):165-71.

BACKGROUND: In endemic areas, gestational malaria is responsible for low birth weight and maternal anaemia. Quinine is the reference treatment for acute malaria in pregnant women, irrespective of term. However, Quinine administration is associated with various side-effects. We evaluated the impact of the homeopathic medicine China rubra 7CH on the side-effects of Quinine used as treatment for acute malaria in pregnant women in Cotonou, Benin. METHODS: This prospective, comparative, randomised study was carried out between June and December 2007 in the Saint Jean-Baptiste Medical Centre, Cotonou. Women were included if they were >3 months pregnant and had a clinical diagnosis of malaria confirmed by a positive thick blood smear. The study population was divided into two groups: (i) patients who presented between the 1st and 15th of each month and who received China rubra 7CH plus Quinine (China group); and (ii) patients who presented from the 16th to the end of each month and who received treatment with Quinine only (Standard group). The aim was to compare the frequency of side-effects of Quinine in the two groups until day 6 after the start of treatment. Neither the patients nor the care givers were blinded to study treatment. Statistical comparison of the two groups was carried out with an alpha risk fixed at 5%. RESULTS: 211 women were recruited: 105 received Quinine plus China rubra 7CH (China group) and 106 received Quinine only (Standard group). A decrease in proportion of patients presenting with side-effects was observed in the China group from day 0 to day 6 of follow-up (53.9%-23.3%) whereas the proportion of patients with side-effects in the Standard group did not change significantly (85.9% on day 0 vs. 82.5% on day 6). Ninety-six (72.4%) patients in the China group and 103 (97.2%) in the Standard group reported at least one side-effect during follow-up (p < 0.0001). The most frequently reported side-effects were tinnitus, dizziness and asthenia. CONCLUSIONS: This preliminary study shows the interest of China rubra 7CH in limiting the side-effects of Quinine used for the treatment of acute malaria in pregnant women.

Building the world's supply of quinine: Dutch colonialism and the origins of a global pharmaceutical industry.[Pubmed:24287061]

Endeavour. 2014 Mar;38(1):8-18.

Quinine, a naturally occurring alkaloid from the Cinchona tree, was one of the first drugs produced and sold by a global pharmaceutical industry during the nineteenth century. Factories in Europe and North America dominated the manufacturing industry, and between 1890 and 1940, Cinchona plantations on Java supplied most of the bark for the Quinine pharmaceutical business. At the end of the nineteenth century, the Dutch colonial state kept a hands-off approach to the Cinchona enterprises, in keeping with its liberal orientation. But the persistent low-price for bark, which led to the near ruin of the Cinchona planters, eventually pushed the colonial state to actively protect the Cinchona plantations. Colonial officials sought to stabilize the colonial Cinchona export-business by encouraging the integration of the Quinine industry on a global scale. Most important was the colonial state's sponsorship in 1913 of the Quinine Agreement, establishing a set price for Cinchona bark, which created the world's first pharmaceutical cartel. In the interwar period, an alliance of Dutch government officials, planters, scientists, doctors and drug-makers, working in both the motherland and the colony, actively promoted the expansion of Quinine consumption, as well as the merit of the Quinine Agreement, which they argued supplied guaranteed a steady supply of Quinine, all for the wellbeing of global humanity.

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.[Pubmed:21609473]

Malar J. 2011 May 24;10:144.

Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented. However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs. This article reviews the historical role of Quinine, considers its current usage and provides insight into its appropriate future use in the treatment of malaria. In light of recent research findings intravenous artesunate should be the first-line drug for severe malaria, with Quinine as an alternative. The role of rectal Quinine as pre-referral treatment for severe malaria has not been fully explored, but it remains a promising intervention. In pregnancy, Quinine continues to play a critical role in the management of malaria, especially in the first trimester, and it will remain a mainstay of treatment until safer alternatives become available. For uncomplicated malaria, artemisinin-based combination therapy (ACT) offers a better option than Quinine though the difficulty of maintaining a steady supply of ACT in resource-limited settings renders the rapid withdrawal of Quinine for uncomplicated malaria cases risky. The best approach would be to identify solutions to ACT stock-outs, maintain Quinine in case of ACT stock-outs, and evaluate strategies for improving Quinine treatment outcomes by combining it with antibiotics. In HIV and TB infected populations, concerns about potential interactions between Quinine and antiretroviral and anti-tuberculosis drugs exist, and these will need further research and pharmacovigilance.

Description

Quinine is an anti-malaria agent and also a potassium channel inhibitor with an IC50 of 169 μM.

Keywords:

Quinine,130-95-0,Chinine; 6'-Methoxycinchonidine,Natural Products, buy Quinine , Quinine supplier , purchase Quinine , Quinine cost , Quinine manufacturer , order Quinine , high purity Quinine

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: